ALYSSA EINSTEIN: Open Payments
NPI 1417710286 · MARIETTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,114 in 67 payments from 17 companies in 2025. Trend: 2023 $0 · 2024 $1,200 · 2025 $2,114
Food & beverage: $2,014Education: $100
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 7 | $587 |
| GENZYME CORPORATION | 7 | $402 |
| Organon LLC | 8 | $205 |
| Janssen Biotech, Inc. | 12 | $198 |
| ABBVIE INC. | 7 | $156 |
| Arcutis Biotherapeutics, Inc. | 4 | $76 |
| LEO Pharma Inc. | 3 | $72 |
| Lilly USA, LLC | 3 | $66 |
| Almirall LLC | 2 | $52 |
| Galderma Laboratories, L.P. | 3 | $51 |
Products named: DUPIXENT, TREMFYA, VTAMA, SKYRIZI, Zoryve, Seysara, NEMLUVIO, CIBINQO.
Industry payments across GA — which companies pay providers there.
